Clinical Trial Update: Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating evolocumab in combination with statin therapy in adults with diabetes and hyperlipidemia or mixed dyslipidemia; completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Hyperlipidemia
• Mixed Dyslipidemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Amgen | Conditions: Diabetes, Hyperlipidemia, Mixed Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2019-01-11